Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation

Transplant Infectious Disease

Volumn 17, Issue 1, 2015, Pages 33-38

  Nesher, L ^a   Rolston, K V I ^a   Shah, D P ^a   Tarrand, J T ^a   Mulanovich, V ^a   Ariza Heredia, E J ^a   Chemaly, R F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Multidrug resistant; Pseudomonas aeruginosa; Stem cell transplantation; Stool culture; Surveillance

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL SKIN DISEASE; BLOODSTREAM INFECTION; CHILD; CHRONIC LEUKEMIA; DISEASE COURSE; FECES MICROFLORA; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MULTIDRUG RESISTANCE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; URINARY TRACT INFECTION; ADVERSE EFFECTS; ALLOTRANSPLANTATION; FECES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INFECTION CONTROL; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SENTINEL SURVEILLANCE; TEXAS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FECES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SENTINEL SURVEILLANCE; TEXAS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84923228267     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12323     Document Type: Article

References (20)

1. Safdar A, Armstrong D. Infections in patients with hematologic neoplasms and hematopoietic stem cell transplantation: neutropenia, humoral, and splenic defects. Clin Infect Dis 2011; 53 (8): 798-806.
2. Mikulska M, Del Bono V, Bruzzi P, et al. Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients. Infection 2012; 40 (3): 271-278.
3. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52 (4): e56-e93.
4. Rosa RG, Goldani LZ. Cohort Study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia. Antimicrob Agents Chemother 2014; 58 (7): 3799-3803.
5. Bhusal Y, Mihu CN, Tarrand JJ, Rolston KV. Incidence of fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States. Chemotherapy 2011; 57 (4): 335-338.
6. Rangaraj G, Granwehr BP, Jiang Y, Hachem R, Raad I. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms. Cancer 2010; 116 (4): 967-973.
7. Taur Y, Xavier JB, Lipuma L, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012; 55 (7): 905-914.
8. Matar MJ, Tarrand J, Raad I, Rolston KV. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 2006; 34 (8): 534-536.
9. Liss BJ, Vehreschild JJ, Cornely OA, et al. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection 2012; 40 (6): 613-619.
10. Martis N, Leroy S, Blanc V. Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections: a narrative review for the clinician. J Infect 2014; 69 (1): 1-12.
11. Steinbrückner B, Fehrenbach J, Philippczik G, Kist M, Bauer TM. Clinical significance of pure or predominant growth of Pseudomonas aeruginosa in faecal specimens of medical patients. J Hosp Infect 1999; 43 (2): 164-165.
12. Cheng YL, Lee HC, Yeung CY, Chan WT. Clinical significance in previously healthy children of Pseudomonas aeruginosa in the stool. Pediatr Neonatol 2009; 50 (1): 13-17.
13. Ohara T, Itoh K. Significance of Pseudomonas aeruginosa colonization of the gastrointestinal tract. Intern Med 2003; 42 (11): 1072-1076.
14. Bodey GP. Epidemiological studies of Pseudomonas species in patients with leukemia. Am J Med Sci 1970; 260 (2): 82-89.
15. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA, USA: CLSI, 2010.
16. Nesher L, Rolston KV. The current spectrum of infection in cancer patients with chemotherapy related neutropenia. Infection 2014; 42 (1): 5-13.
17. Hakki M, Limaye AP, Kim HW, Kirby KA, Corey L, Boeckh M. Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation. Bone Marrow Transplant 2007; 39 (11): 687-693.
18. Rolston KV, Tarrand JJ. Pseudomonas aeruginosa-still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer center. Clin Infect Dis 1999; 29 (2): 463-464.
19. Rolston KV. Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia. Clin Infect Dis 2005; 40 (Suppl 4): S246-S252.
20. Araoka H, Kimura M, Abe M, Takahashi N, Yoneyama A. Appropriate sampling sites for the surveillance of multidrug-resistant Pseudomonas aeruginosa colonization. Jpn J Infect Dis 2014; 67 (2): 118-119.